| Literature DB >> 29510241 |
Satoshi Akamine1, Yoshito Ishizaki1, Yasunari Sakai2, Hiroyuki Torisu3, Ryoko Fukai4, Noriko Miyake4, Kazuhiro Ohkubo1, Hiroshi Koga1, Masafumi Sanefuji1, Ayumi Sakata5, Masahiko Kimura6, Seiji Yamaguchi6, Osamu Sakamoto7, Toshiro Hara1, Hirotomo Saitsu8, Naomichi Matsumoto4, Shouichi Ohga1.
Abstract
Mutations in the X-linked gene CDKL5 cause early-onset epileptic encephalopathy and severe developmental delay. Because this disorder predominantly affects females, the full clinical spectrum of male patients remains elusive. We herein report a 16-year-old boy, who suffered from intractable seizures 20 days after birth. Serial electroencephalograms detected recurrent focal epileptiform discharges from age 4 months, which evolved to hypsarrhythmia later in infancy. Mass-spectrometric analyses revealed increase in urinary excretion of methylmalonic acid without perturbed concentrations of propionic acid, homocystein and methionine. Whole-exome sequencing identified a de novo, truncating mutation in CDKL5 (NM_003159.2:c.419dupA, p.Asn140Lysfs*8). Targeted sequencing excluded concomitant mutations in methylmalonic academia-associated genes. No methylmalonic acidemia has been reported in children with CDKL5 disorder. Extensive analyses on organic acid metabolism for males with CDKL5 mutations will gain more insight into their biochemical profiles in infancy.Entities:
Keywords: CDKL5; De novo mutation; Early-onset epileptic encephalopathy; Methylmalonic acidemia; Whole-exome sequencing
Mesh:
Substances:
Year: 2018 PMID: 29510241 DOI: 10.1016/j.ejmg.2018.03.003
Source DB: PubMed Journal: Eur J Med Genet ISSN: 1769-7212 Impact factor: 2.708